Sustainability | July 26, 2023
Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023)
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
This product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated
